메뉴 건너뛰기
European Urology
Volumn 66, Issue 2, 2014, Pages 263-264
So much cost, such little progress
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; MITOMYCIN;
EID: 84904040893     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.02.031     Document Type: Editorial
Times cited : (14)
References (10)
  • 1
    • 84893808963 scopus 로고    scopus 로고
    • The future of bladder cancer care in the USA
    • A.L. Kaplan, M.S. Litwin, and K. Chamie The future of bladder cancer care in the USA Nat Rev Urol 11 2014 59 62
    • (2014) Nat Rev Urol , vol.11 , pp. 59-62
    • Kaplan, A.L.1    Litwin, M.S.2    Chamie, K.3
  • 3
    • 84883813935 scopus 로고    scopus 로고
    • EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2013
    • M. Babjuk, M. Burger, and R. Zigeuner et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013 Eur Urol 64 2013 639 653
    • (2013) Eur Urol , vol.64 , pp. 639-653
    • Babjuk, M.1    Burger, M.2    Zigeuner, R.3
  • 4
    • 33745712627 scopus 로고    scopus 로고
    • Diagnostic tests and algorithms used in the investigation of haematuria: Systematic reviews and economic evaluation
    • xi-259
    • M. Rodgers, J. Nixon, and S. Hempel et al. Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation Health Technol Assess 10 2006 iii iv xi-259
    • (2006) Health Technol Assess , vol.10
    • Rodgers, M.1    Nixon, J.2    Hempel, S.3
  • 6
    • 84904068134 scopus 로고    scopus 로고
    • The economics of bladder cancer: Costs and considerations of caring for this disease
    • R.S. Svatek, B.K. Hollenbeck, and S. Holmäng et al. The economics of bladder cancer: costs and considerations of caring for this disease Eur Urol 66 2014 253 262
    • (2014) Eur Urol , vol.66 , pp. 253-262
    • Svatek, R.S.1    Hollenbeck, B.K.2    Holmäng, S.3
  • 7
    • 84894420746 scopus 로고    scopus 로고
    • EAU guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2013 guidelines
    • J.A. Witjes, E. Compérat, and N.C. Cowan et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines Eur Urol 65 2014 778 792
    • (2014) Eur Urol , vol.65 , pp. 778-792
    • Witjes, J.A.1    Compérat, E.2    Cowan, N.C.3
  • 8
    • 84859880855 scopus 로고    scopus 로고
    • Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer
    • N.D. James, S.A. Hussain, and E. Hall et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer N Engl J Med 366 2012 1477 1488
    • (2012) N Engl J Med , vol.366 , pp. 1477-1488
    • James, N.D.1    Hussain, S.A.2    Hall, E.3
  • 9
    • 76649099556 scopus 로고    scopus 로고
    • Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
    • iii-iv
    • G. Mowatt, S. Zhu, and M. Kilonzo et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer Health Technol Assess 14 2010 1 331 iii-iv
    • (2010) Health Technol Assess , vol.14 , pp. 1-331
    • Mowatt, G.1    Zhu, S.2    Kilonzo, M.3
  • 10
    • 84893757621 scopus 로고    scopus 로고
    • Urinary EpCAM in urothelial bladder cancer patients: Characterisation and evaluation of biomarker potential
    • R.T. Bryan, N.J. Shimwell, and W. Wei et al. Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential Br J Cancer 110 2014 679 685
    • (2014) Br J Cancer , vol.110 , pp. 679-685
    • Bryan, R.T.1    Shimwell, N.J.2    Wei, W.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.